Full Text View
Tabular View
No Study Results Posted
Related Studies
Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal Women
This study has been completed.
Study NCT00504166   Information provided by University of California, San Francisco
First Received: July 17, 2007   Last Updated: April 16, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Osteopenia
Osteoporosis
Additional conditions recognized in this trial
Bone Diseases, Metabolic
More general conditions related to this trial
Bone Diseases
Musculoskeletal Diseases
Interventions listed in this trial
alendronate
More general drug interventions related to this trial
Bone Density Conservation Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
University of California, San Francisco
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services